...
首页> 外文期刊>Cell death & disease. >Chemerin reverses neurological impairments and ameliorates neuronal apoptosis through ChemR23/CAMKK2/AMPK pathway in neonatal hypoxic–ischemic encephalopathy
【24h】

Chemerin reverses neurological impairments and ameliorates neuronal apoptosis through ChemR23/CAMKK2/AMPK pathway in neonatal hypoxic–ischemic encephalopathy

机译:凯莫瑞通过ChemR23 / CAMKK2 / AMPK途径逆转新生儿缺氧缺血性脑病的神经系统损害并改善神经元凋亡

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Hypoxic–ischemic encephalopathy (HIE) is a devastating neurological event that contributes to the prolonged neurodevelopmental consequences in infants. Therapeutic strategies focused on attenuating neuronal apoptosis in the penumbra appears to be promising. Given the increasingly recognized neuroprotective roles of adipokines in HIE, we investigated the potential anti-apoptotic roles of a novel member of adipokines, Chemerin, in an experimental model of HIE. In the present study, 10-day-old rat pups underwent right common carotid artery ligation followed by 2.5?h hypoxia. At 1?h post hypoxia, pups were intranasally administered with human recombinant chemerin (rh-chemerin). Here, we showed that rh-chemerin prevented the neuronal apoptosis and degeneration as evidenced by the decreased expression of the pro-apoptotic markers, cleaved caspase 3 and Bax, as well as the numbers of Fluoro-Jade C and TUNEL-positive neurons. Furthermore, rh-Chemerin reversed neurological and morphological impairments induced by hypoxia–ischemia in neonatal rats at 24?h and 4 weeks after HIE. In addition, chemerin-mediated neuronal survival correlated with the elevation of chemerin receptor 23 (chemR23), phosphorylated calmodulin-dependent protein kinase kinase 2 (CAMKK2), as well as phosphorylated adenosine monophosphate-activated protein kinase (AMPK). Specific inhibition of chemR23, CAMKK2, and AMPK abolished the anti-apoptotic effects of rh-chemerin at 24?h after HIE, demonstrating that rh-chemerin ameliorated neuronal apoptosis partially via activating chemR23/CAMKK2/AMPK signaling pathway. Neuronal apoptosis is a well-established contributing factor of pathological changes and the neurological impairment after HIE. These results revealed mechanisms of neuroprotection by rh-chemerin, and indicated that activation of chemR23 might be harnessed to protect from neuronal apoptosis in HIE.
机译:缺氧缺血性脑病(HIE)是一种破坏性的神经系统事件,有助于延长婴儿的神经发育后果。专注于减轻半影神经元凋亡的治疗策略似乎很有希望。鉴于脂肪因子在HIE中受到越来越多的神经保护作用,我们在HIE的实验模型中研究了脂肪因子新成员Chemerin的潜在抗凋亡作用。在本研究中,对10日龄的幼犬进行右颈总动脉结扎,然后进行2.5?h缺氧。缺氧后1小时,给小白鼠鼻内施用人重组凯莫瑞(rh-chemerin)。在这里,我们显示了rh-chemerin可以防止神经元凋亡和变性,这由促凋亡标记物,裂解的caspase 3和Bax的表达减少以及Fluoro-Jade C和TUNEL阳性神经元的数量减少所证明。此外,rh-Chemerin在HIE后24?h和4周逆转了新生鼠缺氧缺血引起的神经和形态学损害。此外,凯莫瑞介导的神经元存活与凯莫瑞受体23(chemR23),磷酸化钙调蛋白依赖性蛋白激酶2(CAMKK2)以及磷酸腺苷单磷酸激活蛋白激酶(AMPK)的升高相关。对chemR23,CAMKK2和AMPK的特异性抑制作用取消了HIE后24h时rh-chemerin的抗凋亡作用,表明rh-chemerin通过激活chemR23 / CAMKK2 / AMPK信号通路部分改善了神经元凋亡。神经元凋亡是HIE后病理改变和神经系统损害的公认的促成因素。这些结果揭示了rh-chemerin的神经保护机制,并表明可能利用chemR23的激活来防止HIE中的神经元凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号